Free Trial
ASX:FPH

Fisher & Paykel Healthcare (FPH) Stock Price, News & Analysis

Fisher & Paykel Healthcare logo

About Fisher & Paykel Healthcare Stock (ASX:FPH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
575,466 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Receive FPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

FPH Stock News Headlines

True paradigm shift
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Fisher & Paykel Healthcare Corp Ltd (FPLB.F)
See More Headlines

FPH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Fisher & Paykel Healthcare investors own include ResMed (RMD), CSL (CSL), Mineral Resources (MIN), NVIDIA (NVDA), Accent Group (AX1), Cochlear (COH) and Corporate Travel Management (CTD).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Real Estate
CIK
N/A
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

Net Income
$132.60 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.74 billion
Book Value
A$3.02 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.42
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (ASX:FPH) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners